Showing 1 to 1 of 1 results
cincodias.elpais.com
🌐 75% Global Worthiness
Almirall Celebrates 80 Years, Projects Growth with New Dermatology Drug
Founded 80 years ago in Barcelona, the family-owned Almirall pharmaceutical company, specializing in dermatology, anticipates significant growth with its new drug, Ebglyss, projecting €450 million in sales, while its Ilumetri drug shows 25% yearly growth.
Almirall Celebrates 80 Years, Projects Growth with New Dermatology Drug
Founded 80 years ago in Barcelona, the family-owned Almirall pharmaceutical company, specializing in dermatology, anticipates significant growth with its new drug, Ebglyss, projecting €450 million in sales, while its Ilumetri drug shows 25% yearly growth.
Progress
56% Bias Score
Showing 1 to 1 of 1 results